sophie_paris said:CRP reduction on cardiovascular risk — this is the lab result that excites me most: Baseline hsCRP: 11.0 mg/L (high cardiovascular risk) Month 6…
sophie_paris said:...we're creating a generation dependent on cardiovascular risk...
I understand the concern, but consider this analogy: are we "creating a generation dependent on" blood pressure medication? Cholesterol medication? Thyroid medication?
Obesity is a chronic disease with biological drivers. Treating it with medication is no different from treating any other chronic condition. The "dependency" framing implies weakness or moral failure — neither of which is accurate.
If ongoing medication is what keeps someone healthy, that's successful treatment, not dependency.
A narrower follow-up, since the general answer is now clear:
How would you tell the difference between that and the alternative explanation?
stefan_berlin said:sophie_paris said: ...we're creating a generation dependent on cardiovascular risk...
6 month update on cardiovascular risk: down 41 lbs, off blood pressure meds, A1C normalized. Genuinely life-changing.
PeptideDetective — Independent Peptide Analytics
Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.
View Resultsstefan_berlin said:sophie_paris said: ...we're creating a generation dependent on cardiovascular risk...
Metabolic syndrome resolution on cardiovascular risk: I went from meeting 3 of 5 diagnostic criteria to meeting ZERO after 11 months of treatment.
The 5 criteria (and my journey):
- Waist circumference: 50" → 34" ✅ Resolved
- Triglycerides: 240 → 105 ✅ Resolved
- HDL: 34 → 52 ✅ Resolved
- Blood pressure: 140/94 → 118/72 ✅ Resolved
- Fasting glucose: 120 → 86 ✅ Resolved
Metabolic syndrome reversal is, in my view, the most medically significant outcome of GLP-1 therapy.
stefan_berlin said:sophie_paris said: ...we're creating a generation dependent on cardiovascular risk...
This answered a question I did not know how to ask.